臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationStatement: 胰臟炎的用藥聲明資料

胰臟炎的用藥聲明資料

用藥聲明的狀態：Active ( Medication Status Codes#active)

用藥聲明的分類： Outpatient ( MedicationDispense Category Codes#outpatient)

藥品：阿司匹林(ASPIRIN TABLETS 500MG S.Y.) ( 臺灣健保用藥品項#A003092100)

病人：Patient/pat-example "陳加玲"

用藥的日期與時間：2023-11-05T08:00:00

提出聲明日期與時間：2023-11-05T10:00:00

聲明原因：胰臟炎(Apoplectic pancreatitis) ( SNOMED CT#303002)

藥品使用方式：

時間間隔：2 per 1 days
方式：口服(Oral route) ( SNOMED CT#26643006)
備註：每日早晚各一次，每次一片。